A reliable source said the COVID-19 vaccine for children is one of many important issues that will be discussed at the government summit on vaccination guidelines over the next two weeks.
India’s National Immunity Technical Advisory Group (NTAGI) will also develop comprehensive plans to supplement the elderly with the COVID-19 vaccine, said people who were first aware of the problem.
The source said immunizations for children with communicable diseases will begin in January and asked not to come forward. By March, all other children would be eligible for the vaccine, they said.
The importance of the booster dose for the elderly is important, as some countries have needed better protection against coronaviruses with additional doses. Children are now considered an important group for immunization as schools begin classes in many states depending on the outbreak. After the second disaster that claimed the lives of billions of people in India, one wonders if children will be more at risk because adults are less vaccinated at least once, if not both.
The debate over whether a vaccine should be administered is ongoing among policymakers and scientists around the world. The United States will be the most recent country to introduce COVID-19 support measures beyond transmission, the elderly and other high-risk groups.
Many analysts who follow the data think it’s time to change the data. However, some expressed concern that the first vaccines are still effective in preventing serious illness and death in the general population. Boosters have been a controversial issue for physicians.
An independent United States Food and Drug Administration (USFDA) advocacy group began calling for a narrower model in September against the provision of stimulants that can be used by anyone. Meanwhile, U.S. media reported that the USFDA is planning to expand eligibility without bringing in outside experts.